Unknown

Dataset Information

0

Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations.


ABSTRACT: Deep brain stimulation (DBS) of nucleus basalis of Meynert (NBM) is currently being evaluated as a potential therapy to improve memory and overall cognitive function in dementia. Although, the animal literature has demonstrated robust improvement in cognitive functions, phase 1 trial results in humans have not been as clear-cut. We hypothesize that this may reflect differences in electrode location within the NBM, type and timing of stimulation, and the lack of a biomarker for determining the stimulation's effectiveness in real time. In this article, we propose a methodology to address these issues in an effort to effectively interface with this powerful cognitive nucleus for the treatment of dementia. Specifically, we propose the use of diffusion tensor imaging to identify the nucleus and its tracts, quantitative electroencephalography (QEEG) to identify the physiologic response to stimulation during programming, and investigation of stimulation parameters that incorporate the phase locking and cross frequency coupling of gamma and slower oscillations characteristic of the NBM's innate physiology. We propose that modulating the baseline gamma burst stimulation frequency, specifically with a slower rhythm such as theta or delta will pose more effective coupling between NBM and different cortical regions involved in many learning processes.

SUBMITTER: Kumbhare D 

PROVIDER: S-EPMC6130053 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations.

Kumbhare Deepak D   Kumbhare Deepak D   Palys Viktoras V   Toms Jamie J   Wickramasinghe Chathurika S CS   Amarasinghe Kasun K   Manic Milos M   Hughes Evan E   Holloway Kathryn L KL  

Frontiers in neuroscience 20180903


Deep brain stimulation (DBS) of nucleus basalis of Meynert (NBM) is currently being evaluated as a potential therapy to improve memory and overall cognitive function in dementia. Although, the animal literature has demonstrated robust improvement in cognitive functions, phase 1 trial results in humans have not been as clear-cut. We hypothesize that this may reflect differences in electrode location within the NBM, type and timing of stimulation, and the lack of a biomarker for determining the st  ...[more]

Similar Datasets

| S-EPMC7884989 | biostudies-literature
| S-EPMC5838617 | biostudies-literature
| S-EPMC5759307 | biostudies-literature
| S-EPMC8482375 | biostudies-literature
2015-08-17 | PXD000805 | Pride
| S-EPMC8175342 | biostudies-literature
| S-EPMC7650115 | biostudies-literature
| S-EPMC7346628 | biostudies-literature
| S-EPMC6171218 | biostudies-literature
| S-EPMC6820048 | biostudies-literature